ABBOTT LABORATORIES — Earnings

Most recent reported period: FY2026 (Q1) (filed for period ending 2026-03-31) · sourced from SEC EDGAR

Next earnings (estimated): Tue, June 30, 2026 ~60 days away. Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2026-03-31$11.16B↑+7.8%$1.08B↓-18.7%12.0%
2025-12-31$11.46B↑+4.4%$1.78B↓-80.8%19.6%
2025-09-30$11.37B↑+6.9%$1.64B↓-0.1%18.1%
2025-06-30$11.14B↑+7.4%$1.78B↑+36.6%18.4%
2025-03-31$10.36B↑+4.0%$1.32B↑+8.2%16.3%
2024-12-31$10.97B↑+7.2%$9.23B↑+479.0%17.4%
2024-09-30$10.63B↑+4.9%$1.65B↑+14.6%17.5%
2024-06-30$10.38B↑+4.0%$1.30B↓-5.3%16.1%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2026 (Q1)

Revenue
$11.16B
↑+7.8% +$806M YoY
Net Income
$1.08B
↓-18.7% -$248M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 74 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+0.3pts
52.9%
Operating Margin↓-4.3pts
12.0%
Net Margin↓-3.1pts
9.6%

Go deeper